IMI is a unique Public-Private Partnership (PPP) between the pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA), and the European Communities represented by the European Commission. The First Call of the IMI Joint Undertaking was launched by European Commissioner for Science and Research Janez Potočnik and EFPIA President Arthur Higgins on April 30. and Táňa Perglová.
Imitation and innovation on the Czechoslovak market for technology: Theoretical and methodological basis of research through the lens of business history.
Generální ředitelství Evropské komise pro výzkum a inovace (Directorate-General for Research and Innovation) uspořádalo v Bruselu ve dnech 10. a 11. března 2014 pokračování konference, jež představuje platformu pro diskusi o evropské politice a aktivitách přispívajících k vybudování fungujícího inovačního prostředí v EU. Obsahem a poselstvím navázala na první ročník IC z prosince 2011. and Michaela Vlková.
Innovation Biomedical Centre (IBC) is a multipurpose and newly constructed facility located near to the Institute of Experimental Medicine (Academy of Sciences of the Czech Republic) in Prague-Krč. It was erected between August 2007 and March 2008 at a total cost of 2,1 Mil EURO. IBC was inaugurated by Prime Minister Mirek Topolánek on October 7 2008. and Eva Syková.